NCT00090558View on ClinicalTrials.gov

Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

September 30, 2005

Conditions
Coronary Artery Disease
Interventions
DRUG

nitroglycerin

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00090558 - Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease | Biotech Hunter | Biotech Hunter